CLINICAL TRIALS LIST
The clinical trials list has been updated. See list on this link
Posted September 14, 2016
pCODR Expert Review Committee (pERC) Final Recommendation for Nivolumab in Advanced Kidney Cancer
The Health Technology Assessment review for nivolumab for advanced kidney cancer has concluded with a recommendation that nivolumab be reimbursed, conditional on pending price negotiations with the manufacturer. The pCODR recommendation provides guidance for all provinces except Quebec. pCODR report on this link.
Posted September 2, 2016
COLLECTIVE WISDOM: KIDNEY CANCER UPDATES FROM ASCO 2016
See our latest blog for highlights on the American Society of Clinical Oncology (ASCO) meeting held in Chicago from June 3 to June 7. Read blog on this link
Posted June 22, 2016
MARK YOUR CALENDARS!
2017 Patient & Caregiver Forum
LIVE IT! SURVIVE IT! CURE IT!
Saturday, April 22, 2017
This year, the all-day forum will be held in English and French (simultaneous translation services will be available).